Hyperion DeFi (NASDAQ:HYPD) Releases Earnings Results

Hyperion DeFi (NASDAQ:HYPD) issued its quarterly earnings results on Wednesday. The company reported $0.92 EPS for the quarter, Zacks reports.

Hyperion DeFi Stock Performance

Hyperion DeFi stock traded up $0.05 during trading on Wednesday, hitting $2.69. The stock had a trading volume of 121,860 shares, compared to its average volume of 436,417. The stock’s 50 day moving average is $2.94 and its two-hundred day moving average is $3.36. Hyperion DeFi has a 1 year low of $2.34 and a 1 year high of $15.00. The stock has a market cap of $40.78 million, a price-to-earnings ratio of -0.27 and a beta of 2.53. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12.

Analyst Upgrades and Downgrades

HYPD has been the subject of a number of recent analyst reports. Chardan Capital restated a “buy” rating and issued a $7.30 price objective on shares of Hyperion DeFi in a research note on Tuesday. Zacks Research raised shares of Hyperion DeFi from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 14th. Cantor Fitzgerald increased their price target on shares of Hyperion DeFi from $4.00 to $6.60 and gave the company an “overweight” rating in a research report on Wednesday, July 1st. Finally, Weiss Ratings upgraded shares of Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $6.95.

Insider Transactions at Hyperion DeFi

In other news, insider Hyunsu Jung bought 7,000 shares of the stock in a transaction on Monday, June 1st. The shares were purchased at an average cost of $3.70 per share, for a total transaction of $25,900.00. Following the completion of the purchase, the insider directly owned 1,384,676 shares in the company, valued at $5,123,301.20. This represents a 0.51% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 7.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Hyperion DeFi

Several large investors have recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD bought a new stake in Hyperion DeFi in the 4th quarter valued at about $73,000. State Street Corp purchased a new position in shares of Hyperion DeFi in the fourth quarter worth about $92,000. Geode Capital Management LLC purchased a new position in shares of Hyperion DeFi in the fourth quarter worth about $214,000. Focus Partners Advisor Solutions LLC bought a new stake in shares of Hyperion DeFi in the fourth quarter valued at approximately $221,000. Finally, Jane Street Group LLC bought a new stake in shares of Hyperion DeFi in the fourth quarter valued at approximately $493,000. Hedge funds and other institutional investors own 25.84% of the company’s stock.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.